[ad_1]
A small team of Israeli scientists bet on an innovative treatment that promises to cure cancer in just a few weeks
Side effects will be minimal, if any, and at a much lower cost than currently treated. available in the pharmaceutical industry.
Dr. Dan Aridor, owner of Accelerated Evolution Biotechnologies (AEBi), founded in 2000 within the ITEK incubator, has been ensuring the effectiveness of cancer treatment from the first day. "Our solution will be generic and personal," he said.
The treatment known as MuTaTo (multi-target toxin) has been compared to an "anticancer antibiotic" and is among the most advanced treatments. According to the Jerusalem Post, statistics point to a growing number of cancer cases.
"There are at least 18.1 million diagnoses each year," said the International Agency for Research on Cancer. For the moment, MuTaTo is currently being tested on mice and has already been shown to be effective in inhibiting the growth of cancer cells.
AEBi is about to launch a series of clinical trials that can be completed in a few years and available. treatment in specific cases.
Source link
